Patel Sandip Iinsider trades
In SEC Form 4 filings, Patel Sandip I is listed as Director of Akari Therapeutics Plc (AKTX) and CFO and General Counsel of AtlasClear Holdings, Inc. (ATCH). In the last 90 days, Patel Sandip I bought $20.7K of AtlasClear Holdings, Inc. (ATCH) on the open market and sold none. The largest purchase was $10.9K of AtlasClear Holdings, Inc. (ATCH) on Sep 24. Took part in a cluster buy; the latest at AtlasClear Holdings, Inc. (ATCH), where 5 insiders bought within 2 days, ending Sep 25.
Companies and roles
Cluster buys
- ATCH: 5 insiders bought $162.5K between Sep 24 – Sep 25.
Form 4 historysince 2026-09-28
Dashed line = amended filing (Form 4/A)
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M | 3,866 | $0.00 | $2 | 32,691 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M | 6,186 | $0.00 | $2 | 38,877 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M · derivative | 3,866 | $16.16 | $62,475 | not reported | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M · derivative | 6,186 | $16.16 | $99,966 | not reported | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 5 | Oct 16 | A | 4,313 | $7.90 | $34,068 | 28,825 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Aug 18 | Oct 16 | A | 12,100 | $7.90 | $95,578 | 24,512 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Aug 18 | Oct 16 | A · derivative | 45,000 | $7.90 | $355,455 | 45,000 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Aug 18 | Oct 16 | A · derivative | 15,000 | $7.90 | $118,485 | 15,000 | No | Form 4 |
| ATCHAtlasClear Holdings, Inc. | Oct 1 | Oct 2 | A · derivative | 777,332 | $0.20 | $156,244 | 777,332 | No | Form 4 |
| ATCHAtlasClear Holdings, Inc. | Sep 25 | Sep 284/A | P | 50,000 | $0.20 | Purchase +$9,875 | 905,130 | No | Form 4/A |
| ATCHAtlasClear Holdings, Inc. | Sep 24 | Sep 284/A | P | 50,000 | $0.22 | Purchase +$10,865 | 855,130 | No | Form 4/A |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.